Fresenius plans to cut Fresenius Medical Care stake to about 20%
Fresenius plans to sell approximately 13.4 million Fresenius Medical Care shares, reducing its stake from approximately 25% to approximately 20%. Pricing and allocation are expected before Xetra trading opens on November 12, 2026.
1. Planned share sale
Fresenius plans to sell approximately 13.4 million Fresenius Medical Care shares to institutional investors through an accelerated bookbuild. The sale would reduce its financial investment from approximately 25% to approximately 20% of Fresenius Medical Care’s issued share capital.
2. Proceeds and lock-up
Net proceeds will support capital allocation priorities under #FutureFresenius and create capacity to redeploy capital into growth platforms. The remaining shares will be subject to a 90-day lock-up, with customary exceptions.
